Understanding and Treating Acute Coronary Syndrome

To receive credit, visit: http://freece.com/FreeCE/CECatalog_Details.aspx?ID=9d772e0a-fc96-4aa9-8658-4d...

Program Overview
Pharmacists can make a difference in the management and treatment of acute coronary syndrome. This program will educate healthcare providers on ACS treatment guidelines, provide an update on pharmacotherapy, and the challenges associated with ACS treatment so they can more comfortably respond to patients and providers in their role as pharmacist.

Pharmacist Educational Objectives Describe the epidemiology and etiology of acute coronary syndrome (ACS). Outline the evidence and guideline-based role of antiplatelet therapy in the prevention of coronary attacks in patients with acute coronary syndromes (ACS). Describe current and emerging oral antiplatelet strategies for long-term prevention of coronary attacks in ACS patients, including mechanisms of action, efficacy, dose and duration of therapy. Review the pharmacist's role in counseling patients on lifestyle changes, drug treatment strategies and medication adherence to improve the quality of life and long-term maintenance of ACS patients.

Pharmacy Technician Educational Objectives Describe in general terms the role of antiplatelet therapy in the prevention of coronary attacks. Identify medications used in the treatment of acute coronary syndrome.

Accreditation
Pharmacist 0798-0000-10-064-H01-P
Pharmacy Technician 0798-0000-10-064-H01-T

Disclaimer:
The Content and Program Materials contained are provided by FreeCE/PharmCon as a service to its registrants and to the public.
THE INFORMATION OFFERED IS FOR GENERAL EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY. THIS IS NOT INTENDED TO PROVIDE INFORMATION OR ADVICE CONCERNING SPECIFIC PROBLEMS OF SITUATIONS.
IT IS NOT INTENDED AS A SUBSTITUTE FOR THE PROFESSIONALS OWN RESEARCH, OR FOR HIS OWN PROFESSIONAL JUDGMENT OR ADVICE FOR A SPECIFIC PROBLEM OF SITUATION.
NEITHER FREECE/PHARMCON NOR ANY CONTENT PROVIDER INTENDS TO OR SHOULD BE CONSIDERED TO BE RENDERING MEDICAL, PHARMACEUTICAL OR OTHER PROFESSIONAL ADVICE. WHILE FREECE/PHARMCON AND ITS CONTENT PROVIDERS HAVE EXERCISED CARE IN PROVIDING INFORMATION, NO GUARANTEE OF ITS ACCURACY, TIMELINESS OR APPLICABILITY CAN BE OR IS MADE. YOU ASSUME ALL RISKS AND RESPONSIBILITIES WITH RESPECT TO ANY DECISIONS OR ADVICE MADE OR GIVEN AS A RESULT OF THE USE OF THE PROGRAM, PROGRAM MATERIALS, FREECE WEBSITE OR INTERACTION WITH CONTENT PROVIDERS.
IF MEDICAL OR OTHER EXPERT ASSISTANCE IS REQUIRED, YOU SHOULD OBTAIN THE SERVICES OF A COMPETENT PROFESSIONAL.

Category:

Education

Tags:

• CE
• continuing
• education
• free
• online
• pharmacist
• pharmacy
• technician
• acute
• coronary
• syndrome
• ACS

[Fernandohayabusa]

Just for you guys to know Ticagrelor was approved by FDA as of July of 2011.